Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Tabel 1. Probabilitea unor componente de vaccinuri de a<br />
cauza reacÆii imune<br />
Constituent Vaccinuri Probabilitate<br />
Febrå galbenå mare<br />
Pojar–oreion–<br />
rubeolå<br />
micå<br />
Ou Influenzå posibilå<br />
Varicelå<br />
posibilå<br />
Rabie<br />
necunoscutå<br />
Pojar–oreion–<br />
rubeolå<br />
mare<br />
Varicelå<br />
mare<br />
Febrå galbenå mare<br />
Gelatinå Polio micå<br />
Influenzå<br />
posibilå<br />
Bacil<br />
necunoscutå<br />
Calmette–Guérin<br />
Rabie<br />
necunoscutå<br />
Antibiotice<br />
Febrå tifoidå<br />
Diftero–tetano–<br />
pertussis<br />
Hepatitå A çi B<br />
Influenzå<br />
Pojar–oreion–<br />
rubeolå<br />
Polio<br />
Rabie<br />
Varicelå<br />
necunoscutå<br />
micå<br />
micå<br />
micå<br />
micå<br />
micå<br />
micå<br />
micå<br />
BIBLIOGRAFIE<br />
1. Watson JC, Hadler SC, Dykewicz CA et al. Measles,<br />
mumps and rubella: vaccine use and strategies for<br />
elimination of measles, rubella and congenital rubella<br />
syndrome and control of mumps. MMWR Morb<br />
Mortal Wkly Rep 1998; 47:1–57.<br />
2. Kemp A, Van Asperen P, Mukhi A. Measles<br />
immunization in children with clinical reactions to<br />
egg protein. Am J Dis Child. 1990;144:33–35.<br />
3. Pickering LK (ed.). Red Book: 2003 Report of the<br />
Committee on Infectious Diseases, Elk Grove Village,<br />
Ill, Amer Acad Pediatrics. 2003: 390, 427.<br />
4. D’Souza RM, Campbell–Lloyd S, Issacs D et al.<br />
Adverse events following immunisation associated<br />
with the 1988 Australian Measles Control Campaigns.<br />
Commun Dis Intell 2000; 24: 27–33.<br />
5. Hartmann K, Keller–Stanislawski B. Verdachtsfälle<br />
unerwünschter Arzneimittelwirkungen (UAW) nach<br />
Anwendung von Impfstoffen mit attenuierter Masern–<br />
Komponente. Eine Übersicht der nationalen<br />
Spontanerfassungsdaten 1995–1999.<br />
Bundesgesundheitsbl Gesundheitsforsch<br />
Gesundheitsschutz 2001; 44: 981– 986.<br />
6. Fasano MB, Wood RA, Cooke SK, Sampson HA.<br />
Egg hypersensitivity and adverse reactions to measles,<br />
mumps, and rubella vaccine. J Pediatr. 1992; 120:<br />
878– 881.<br />
7. James JM, Burks AW, Roberson PK, Sampson HA.<br />
Safe administration of the measles vaccine to children<br />
allergic to eggs. N Engl J Med. 1995; 332: 1262– 1266.<br />
8. Nakayama T, Aizawa C. Changes in gelatin content<br />
of vaccines associated with reduction in reports of<br />
allergic reactions. J Allergy Clin Immunol, 2000; 106:<br />
591– 592.<br />
9. Kwittken PL, Rosen S, Sweinberg SK. MMR vaccine<br />
and neomycin allergy. Am J Dis Child. 1993; 147:<br />
128– 129.<br />
10. Elliman D, Dha<strong>nr</strong>aj B. Safe MMR vaccination despite<br />
neomycin allergy. Lancet. 1991; 337: 365.<br />
11. Kaaber K, Nielsen AO, Veien NK. Vaccination<br />
granulomas and aluminium allergy. course and prognostic<br />
factors. Contact Dermatitis. 1992; 26: 304– 306.<br />
12. Fawcett HA, Smith NP. Injection–site granuloma due<br />
to aluminum. Arch Dermatol.1984; 120: 1318– 1322.<br />
13. Kelso JM, Cockrell GE, Helm RM, Burks AW.<br />
Common allergens in avian meats. J Allergy Clin<br />
Immunol. 1999; 104: 202– 204.<br />
14. Wantke F, Focke M, Hemmer W et al. Exposure to<br />
formaldehyde and phenol during an anatomy dissecting<br />
course: sensitizing potency of formaldehyde in medical<br />
students. Allergy. 2000; 55: 84– 87.<br />
15. Dannemann A, Van Ree R, Kulig M et al. Specific<br />
IgE and IgG4 immune responses to tetanus and<br />
diphtheria toxoid in atopic and nonatopic children<br />
during the first two years of life. Int Arch Allergy<br />
Immunol. 1996; 111: 262–267.<br />
16. Nilsson L, Kjellman NI, Bjorksten B. A randomized<br />
controlled trial of the effect of pertussis vaccines on<br />
atopic disease. Arch Pediatr Adolesc Med. 1998; 152:<br />
734– 738.<br />
17. Prescott SL, Sly PD, Holt PG. Raised serum IgE<br />
associated with reduced responsiveness to DPT<br />
vaccination during infancy. Lancet. 1988; 351: 1489.<br />
18. Holt PG, Rudin A, Macaubas C et al. Development<br />
of immunologic memory against tetanus toxoid and<br />
pertactin antigens from the diphtheria–tetanus–<br />
pertussis vaccine in atopic versus nonatopic children.<br />
J Allergy Clin Immunol. 2000; 105: 1117– 1122.<br />
19. Khakoo GA, Lack G. Recommendations for using<br />
MMR vaccine in children allergic to eggs. BMJ. 2000;<br />
320: 929– 932.<br />
20. Baxter DN. Measles immunization in children with<br />
a history of egg allergy. Vaccine. 1996; 14: 131– 134.<br />
21. Aukrust L, Almeland TL, Refsum D, Aas K. Severe<br />
hypersensitivity or intolerance reactions to measles<br />
vaccine in six children. Clinical and immunological<br />
studies. Allergy. 1980; 35: 581– 587.<br />
„<strong>Sibiul</strong> <strong>Medical</strong>“ Volum 19 Nr. 4/2007 49